The company is a private general practice offering comprehensive medical services in the comfort of patients’ homes, with over 3,500 members across its geographical coverage area. It delivers a personalised and responsive service that provides its members with quick and accurate diagnoses and rapid implementation of effective treatment plans.

The company offers an unique operating model, with revenue primarily generated from monthly subscription membership fees. Members benefit from unlimited consultations (including home visits) from their dedicated GP and access to a 24/7 private out-of-hours duty doctor.

At present, the company covers a diverse area across central England, which includes several areas popular with the high-net-worth individuals who make up its core demographic.

The company generates and manages a significant number of private referrals to specialist consultants and allied health professionals across its geographical area and increasingly to London. It plays a central role in the selection of private hospitals, clinics and consultants to which its members are referred.

The company is being offered for sale to facilitate the shareholders’ exit to pursue other interests outside general practice. Offers invited.

Key Highlights

– Loyal and satisfied client base, primarily comprising adults aged over 50 with a high level of disposable income.

– ‘Good’ CQC inspection report, with ‘Outstanding’ for responsiveness. The company is a registered designated body with the General Medical Council.

– Has won a large number of national awards from prestigious industry and consumer bodies, including the LaingBuisson Award for Primary Care.

– Unique, proven business model and is in a strong position to scale nationally on a number of different levels and would strategically suit franchise/licensing expansion. Opportunities for scalability are tangible nationally and internationally.

– Strongly placed to leverage relationships within the private health sector providing synergies for an existing player to expand or for potential purchasers to monetise downstream revenue. The company instigates and directs over 3,500 private referrals annually, estimated to generate over £7m in resulting secondary care fees.

– In addition to organic growth, there are tangible opportunities for any purchaser to achieve exponential growth via securing private commercial contracts or NHS Contracts. Whilst the company is currently purely private, it is well placed to secure lucrative APMS contracts. It has a track record of securing and delivering both private / NHS contracts in the past.

– Experienced senior management team, with no operational reliance on shareholders.

– Operates from leasehold premises, which provide a permanent consulting space along with office and storage facilities.

Financial Highlights

– Turnover of £2.4m achieved in YE23.

– Adjusted EBITDA of £386k in the same year.

– Projected turnover of £3m for YE24, with an adjusted EBITDA of £411k.

– Turnover expected to rise to £3.6m in YE25 and £4.7m in YE26.

– Average gross profit margin of 51%.

– High level of regular, repeat and predictable income, with monthly subscription fees accounting for circa 80% of turnover.

– Has invested in planned growth, with sufficient current capacity to support an increase of over 80% in income through a minimal increase in COGS or overheads and new subscription monthly income rising by circa £4.5k pcm.

– Industry revenue is expected to grow at a compound annual rate of 3.6% over the next five years, reaching £18.7bn by 2029.